Oral versus intravenous methylprednisolone for the treatment of multiple sclerosis relapses: A meta-analysis of randomized controlled trials

BACKGROUND: Intravenous glucocorticoids are recommended for multiple sclerosis (MS). However, they can be inconvenient and expensive. Due to their convenience and low cost, oral glucocorticoids may be an alternative treatment. Recently, several studies have shown that there is no difference in effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shuo, Liu, Xiaoqiang, Chen, Shuying, Xiao, Yingxiu, Zhuang, Weiduan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703548/
https://www.ncbi.nlm.nih.gov/pubmed/29176905
http://dx.doi.org/10.1371/journal.pone.0188644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703548/
https://www.ncbi.nlm.nih.gov/pubmed/29176905
http://dx.doi.org/10.1371/journal.pone.0188644

Ejemplares similares